AI Technology Application in Medical Care of NSCLC Based on Patent Trend Analysis

Cheng-Wen Lee and Shu Hui Chen

Advances in Management and Applied Economics, 2021, vol. 11, issue 6, 6

Abstract: The patent trend analysis provides sound knowledge about the possibility of exploring potential innovation/R&D and gives an insight into which countries and companies are mostly investing in artificial intelligence (AI) technologies involved with non-small cell lung cancer (NSCLC) medical care. By comparing patent indicators changes of two decades from 2001 to 2020, the most active countries and companies are identified to provide perceptions of global patent variations. In line with this, we apply a comprehensive software INNOVUE to analyze the patent trend based on the Worldwide Patent Office database. According to previous research, 315 patents are selected as the appropriate patent analysis data. The analysis result is a series of trend maps that show the trend of patent development from the early stage to current changes. This study findings evaluate government’s/company’s concern and motivation about the investment in R&D capability of AI technology-related patents, and indicate who plays the main role around the world regarding the application of AI combined with NSCLC medical treatment. JEL classification numbers: C80, D81, E27.

Keywords: Patent trend analysis; Artificial intelligence technologies; NSCLC. (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.scienpress.com/Upload/AMAE%2fVol%2011_6_6.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spt:admaec:v:11:y:2021:i:6:f:11_6_6

Access Statistics for this article

More articles in Advances in Management and Applied Economics from SCIENPRESS Ltd
Bibliographic data for series maintained by Eleftherios Spyromitros-Xioufis ().